Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Heng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0103-2173; OpenAlex author ID A5100373113. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. Self-Amplified Nanomedicine Enables Lysosomal Blockade to Potentiate Starvation Therapy of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1002/adma.202519523↗
  2. Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP. Co-author DOI 10.1038/s41423-026-01390-2↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mingjie Song · 1 shared paper, 2026 · strength 0.29
  2. Xuan Pan · 1 shared paper, 2026 · strength 0.29
  3. Bo Huang · 1 shared paper, 2026 · strength 0.23
  4. Yabo Zhou · 1 shared paper, 2026 · strength 0.23
  5. Zi Wang · 1 shared paper, 2026 · strength 0.23
  6. Jiadi Lv · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.